CN102988691B - Preparation method and application of liver-strengthening tablet - Google Patents

Preparation method and application of liver-strengthening tablet Download PDF

Info

Publication number
CN102988691B
CN102988691B CN201210389746.7A CN201210389746A CN102988691B CN 102988691 B CN102988691 B CN 102988691B CN 201210389746 A CN201210389746 A CN 201210389746A CN 102988691 B CN102988691 B CN 102988691B
Authority
CN
China
Prior art keywords
preparation
extraction
ethanol
radix
microwave
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201210389746.7A
Other languages
Chinese (zh)
Other versions
CN102988691A (en
Inventor
李碧英
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHONGQING HONOROAD ANIMAL HEALTH CO., LTD.
Original Assignee
CHONGQING HONOROAD ANIMAL HEALTH Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHONGQING HONOROAD ANIMAL HEALTH Co Ltd filed Critical CHONGQING HONOROAD ANIMAL HEALTH Co Ltd
Priority to CN201210389746.7A priority Critical patent/CN102988691B/en
Publication of CN102988691A publication Critical patent/CN102988691A/en
Application granted granted Critical
Publication of CN102988691B publication Critical patent/CN102988691B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a preparation method of a liver-strengthening tablet. The liver-strengthening tablet is prepared by using 100g of daylily roots, 150g of isatis roots, 250g of oriental wormwoods, 150g of danshen roots and 100g of Chinese dates as bulk drugs and adopting supercritical extraction and microwave-assisted extraction modes. By adopting the method, the ketone content of the danshen root is greatly improved; and the invention also provides application of the liver-strengthening tablet in preparation of drugs for inhibiting cell proliferation of mice melanoma cells B16.

Description

A kind of preparation method of strong liver sheet and application
Technical field
The present invention relates to Chinese medicine preparation technical field, be specifically related to a kind of preparation method and application of strong liver sheet.
Background technology
Strong liver sheet is recorded in Ministry of Public Health standard WS3-B-0376-90, by Radix Hemerocallis 100g, Radix Isatidis 150g, Herba Artemisiae Scopariae 250g, Radix Salviae Miltiorrhizae 150g, Fructus Jujubae 100g, as crude drug, is made, can clearing away heat-damp and promoting diuresis.For acute hepatitis.
In prior art, not yet there is strong liver sheet to adopt the report of supercritical and microwave technology extracting aspect preparation, and adopt the method that powder and decocting boil of beating, technique is coarse, backward, and impurity is many, causes patient's consumption excessive, be inconvenient to take, had a strong impact on this product and applied clinically.
Summary of the invention
Goal of the invention: in order to address the above problem, the object of the present invention is to provide a kind of preparation method of strong liver sheet.
Another object of the present invention is to provide a kind of strong liver sheet to suppress the application in B16 mouse melanoma cell line cell proliferation medicine in preparation.
Technical scheme: the object of the invention is to realize by following scheme:
A kind of preparation method of strong liver sheet, by Radix Hemerocallis 100g, Radix Isatidis 150g, Herba Artemisiae Scopariae 250g, Radix Salviae Miltiorrhizae 150g, Fructus Jujubae 100g, as crude drug, made, described method is comprised of the following step: get Herba Artemisiae Scopariae, join in CO2 supercritical extraction device, ethanol is as entrainer, and the percent by volume that entrainer accounts for total extractant is 4-6%, extracting pressure 15-30MPa, temperature 30-50 ℃, CO 2flow 1-3m1/g crude drug min, extraction time 150-180min, obtains supercritical extract, standby; Get Radix Hemerocallis, Radix Isatidis, Radix Salviae Miltiorrhizae, Fructus Jujubae, pulverize, add 70% ethanol of 2L, drop in microwave extracting apparatus and carry out microwave extracting, extraction power 400-600W, extracts 2 times, each 4-8 minute, combining extraction liquid, concentrated, be added on polyamide chinlon 66 chromatographic columns, 50% ethanol elution, collects 5 times of amount column volume eluents, decompression recycling ethanol, concentrate and be dried, obtain microwave extraction thing, standby; Above-mentioned supercritical extract and microwave extraction thing are mixed, add starch, 70% ethanol granule processed, dry, tabletting, makes 1000, every heavy 0.5g.
The preparation method of above-mentioned a kind of strong liver sheet, described CO 2the percent by volume that supercritical extraction entrainer accounts for total extractant is 5%.
The preparation method of above-mentioned a kind of strong liver sheet, described microwave extracting power 500W extracts 6 minutes at every turn.
The preparation method of above-mentioned a kind of strong liver sheet, described CO 2the extracting pressure 20MPa of supercritical extraction, 40 ℃ of temperature, CO 2flow 2ml/g crude drug min, extraction time 160min.
Above-mentioned strong liver sheet suppresses the application in B16 cell proliferation medicine in preparation.
In prior art, strong every 0.55g of liver sheet, each 8-10 sheet, 2 times on the one, the every 0.5g of strong liver sheet that adopts the present invention to be prepared into only needs 3 at every turn, within 1st, takes 2 times, has greatly reduced dose having under the condition of more active component.This conclusion can be by following evidence.
The comparison of TANSHINONES content in strong liver sheet prepared by test one, distinct methods
1, the strong liver sheet of instrument and reagent the present invention: press embodiment 3 method preparations, use 690g crude drug, make 1500 through extracting, every heavy 0.5g.Former strong liver sheet, by the preparation of ministry standard method, is used 690g crude drug, through extracting, makes 1652, every heavy 0.5g.Agilent 1200 high performance liquid chromatographs; METTLERAE240 electronic analytical balance; TANSHINONES reference substance (Nat'l Pharmaceutical & Biological Products Control Institute).
2, method
Chromatographic condition and system suitability: with octadecylsilane chemically bonded silica, be filler; Methanol-water-phosphoric acid (40:60:0.2) is mobile phase; Detection wavelength is 280nm.Number of theoretical plate calculates by TANSHINONES peak, should be not less than 3000.
The preparation of reference substance solution: precision takes at 60 ℃ of drying under reduced pressure TANSHINONES reference substance of 4 hours appropriate, adds methanol and makes every 1ml containing the solution of 18 μ g, obtains.
The preparation of need testing solution: get the strong liver sheet of the present invention and former strong liver sheet, porphyrize, mixes, and gets 1g, accurately weighed, and precision adds 70% ethanol 20ml, close plug, supersound process 10 minutes, centrifugal, get supernatant, obtain.
Algoscopy is accurate reference substance solution and each 20 μ l of need testing solution of drawing respectively, and injection liquid chromatography, measures, and obtains.
3, result
Result shows, in the strong liver sheet of the present invention, the content of TANSHINONES is 1.43mg/ sheet; And the content of TANSHINONES is 0.24mg/ sheet in former strong liver sheet, in the situation that dose reduces, TANSHINONES content improves a lot.
Above-mentioned research shows, the strong liver sheet that adopts the present invention to prepare, and active constituent content is higher than the standby strong liver sheet of ministry standard legal system.
The specific embodiment
Form by the following examples, foregoing of the present invention is described in further detail again, but this should be interpreted as to the scope of the above-mentioned theme of the present invention only limits to following example, all technology realizing based on foregoing of the present invention all belong to scope of the present invention.
Embodiment 1
Get Radix Hemerocallis 100g, Radix Isatidis 150g, Herba Artemisiae Scopariae 250g, Radix Salviae Miltiorrhizae 150g, Fructus Jujubae 100g, by Herba Artemisiae Scopariae, join CO 2in supercritical extraction device, ethanol is as entrainer, and the percent by volume that entrainer accounts for total extractant is 4%, extracting pressure 15MPa, 30 ℃ of temperature, CO 2flow 1m1/g crude drug min, extraction time 150min, obtains supercritical extract, standby; Get Radix Hemerocallis, Radix Isatidis, Radix Salviae Miltiorrhizae, Fructus Jujubae, pulverize, add 70% ethanol of 2L, drop in microwave extracting apparatus and carry out microwave extracting, extraction power 400W, extracts 2 times, each 4 minutes, combining extraction liquid, concentrated, be added on polyamide chinlon 66 chromatographic columns, 50% ethanol elution, collects 5 times of amount column volume eluents, decompression recycling ethanol, concentrate and be dried, obtain microwave extraction thing, standby; Above-mentioned supercritical extract and microwave extraction thing are mixed, add starch, 70% ethanol granule processed, dry, tabletting, makes 1000, every heavy 0.5g.
After testing, in finished product, the content of TANSHINONES is 1.48mg/ sheet.
Embodiment 2
Get Radix Hemerocallis 100g, Radix Isatidis 150g, Herba Artemisiae Scopariae 250g, Radix Salviae Miltiorrhizae 150g, Fructus Jujubae 100g, by Herba Artemisiae Scopariae, join CO 2in supercritical extraction device, ethanol is as entrainer, and the percent by volume that entrainer accounts for total extractant is 6%, extracting pressure 30MPa, temperature 50 C, CO 2flow 3m1/g crude drug min, extraction time 180min, obtains supercritical extract, standby; Get Radix Hemerocallis, Radix Isatidis, Radix Salviae Miltiorrhizae, Fructus Jujubae, pulverize, add 70% ethanol of 2L, drop in microwave extracting apparatus and carry out microwave extracting, extraction power 600W, extracts 2 times, each 8 minutes, combining extraction liquid, concentrated, be added on polyamide chinlon 66 chromatographic columns, 50% ethanol elution, collects 5 times of amount column volume eluents, decompression recycling ethanol, concentrate and be dried, obtain microwave extraction thing, standby; Above-mentioned supercritical extract and microwave extraction thing are mixed, add starch, 70% ethanol granule processed, dry, tabletting, makes 1000, every heavy 0.5g.
After testing, in finished product, the content of TANSHINONES is 1.53mg/ sheet.
Embodiment 3
Get Radix Hemerocallis 100g, Radix Isatidis 150g, Herba Artemisiae Scopariae 250g, Radix Salviae Miltiorrhizae 150g, Fructus Jujubae 100g, by Herba Artemisiae Scopariae, join CO 2in supercritical extraction device, ethanol is as entrainer, and the percent by volume that entrainer accounts for total extractant is 5%, extracting pressure 20MPa, 40 ℃ of temperature, CO 2flow 2m1/g crude drug min, extraction time 160min, obtains supercritical extract, standby; Get Radix Hemerocallis, Radix Isatidis, Radix Salviae Miltiorrhizae, Fructus Jujubae, pulverize, add 70% ethanol of 2L, drop in microwave extracting apparatus and carry out microwave extracting, extraction power 500W, extracts 2 times, each 6 minutes, combining extraction liquid, concentrated, be added on polyamide chinlon 66 chromatographic columns, 50% ethanol elution, collects 5 times of amount column volume eluents, decompression recycling ethanol, concentrate and be dried, obtain microwave extraction thing, standby; Above-mentioned supercritical extract and microwave extraction thing are mixed, add starch, 70% ethanol granule processed, dry, tabletting, makes 1000, every heavy 0.5g.
After testing, in finished product, the content of TANSHINONES is 1.43mg/ sheet.
Embodiment 4: strong liver sheet suppresses the experimentation data of B16 cell proliferation
1 experiment material
1.1 experiment cell strains
Mouse melanin tumor cell (B16), Nanjing Zhengkuan Pharmaceutical Technology Co., Ltd.'s laboratory cell bank, DMEM+10%FBS cellar culture.
1.2 Experimental agents
Drugs: the present invention is good for liver sheet: press embodiment 3 method preparations.
Medicinal liquid liquid storage: take the strong liver sheet of 100mg, be dissolved in 5ml dehydrated alcohol, 0.2 μ m filter filters, 500 μ l doff pipe subpackages ,-20 ℃ of storages, 0.2 μ m filter filters dehydrated alcohol in order to the use of matched group simultaneously.
1.3 experiment reagent
The Cat.No.12100-061Lot.No.758137 of DMEM(GIBCO company); Hyclone (Lot.No.100419 of Tian Hang bio tech ltd, Zhejiang); The NaHCO3(Shanghai Jiu Yi chemical reagent Cat.No.11810-033Lot.No.1088387 of company limited); Trypsin(AMRESCO company lot number: 2010/04); EDTA(AMRESCO company lot number: 2009/10); Penicillin G Sodium Salt(AMRESCO company lot number: 2010242); Streptomycin Sulfate(AMRESCO company lot number: 2010382); Dehydrated alcohol (Nanjing Chemistry Reagent Co., Ltd.'s lot number: 080310182); MTT (Biosharp lot number: 0793); The autogamy of PBS(laboratory);
1.4 experiment equipment
Lycra inverted microscope (German Leica model: DM1L); Visible-ultraviolet light microwell plate detector (U.S. MD company model: SPECTRAMAX 190); CO2 incubator (FORMA model: 3111); (safe and sound company of Su Jing group manufactures model to super-clean bench: SW-CJ-ZFD); Pure water instrument (U.S. Spring company model: S/N 020579); Accurate pipettor (French Gilson Inc model: P2); Electronic balance (German Sai Duolisi company limited model: BT323S); Full-automatic high-pressure autoclave (Japanese SANYO company model: MLS-3020); Table electrothermal air dry oven (Shanghai accurate experimental facilities company model: DHG9123A); Refrigerator (Siemens Company's model: KG18V21TI); Liquid nitrogen container (CBS model: 2001); Low speed centrifuge (Anting Scientific Instrument Factory, Shanghai's model: KA-1000); 0.2 μ m filter (MILLIPORE model: SLGP033RB); 10cm culture dish (NEST company), 96 well culture plates (NEST company); Cell counting count board; Centrifuge tube, pipet, Tips are some.
2 experimental techniques
1) B16 cell carries out cellar culture (10cm culture dish) with DMEM+10%FBS in 37 ℃, 5%CO2, when Growth of Cells is during to logarithmic (log) phase, collecting cell, discards culture fluid, PBS fine laundering 3 times, add 3ml 0.25% trypsin-0.04%EDTA, after 37 ℃ of digestion 2min, add wherein 5ml complete medium neutralization reaction, after piping and druming cell, proceeded in centrifuge tube, the centrifugal 5min of 1000rpm, adjusts 3 * 104/ml of concentration of cell suspension.
2) cell kind is entered in 96 well culture plates, every hole adds cell suspension 180 μ l, culture plate put into cell culture incubator (37 ℃, 5%CO2) cellar culture.
3) according to Growth of Cells situation, generally grow to 50%-70%, add strong liver sheet solution, continue to cultivate 24h.
4) after 24h, add 20 μ l MTT solution (5mg/ml, i.e. 0.5%MTT), continue to cultivate 4h.
5) after 4h, buckle method is removed supernatant, with absorbent paper, pats dry gently, and every hole adds 200 μ l dimethyl sulfoxide, puts low-speed oscillation 10min on shaking table, and crystal is fully dissolved.At enzyme-linked immunosorbent assay instrument 490nm place, measure the light absorption value in each hole.
6) background (do not add cell, only add culture fluid) is set simultaneously, control wells (the medicine dissolution medium of cell, same concentrations, culture fluid, MTT, dimethyl sulfoxide), sets 6 multiple holes for every group.
7) result represents the suppression ratio of cell with medicine:
Cell increment suppression ratio (%)=(control wells OD value-dosing holes OD value)/control wells OD value * 100%.Experiment repeats 3 times.
3 statistical dispositions
Adopt correlation analysis and Student t check in Microsoft Excel 2003 softwares, data represent with mean ± S.D..
4 experimental results
Statistical result showed after mtt assay experiment, with matched group comparison, when dosage reaches 5mg/ml, to B16 cell inhibitory effect variant (P<0.05), dosage this difference when 10mg/ml has significance (P<0.01), has utmost point significant difference (P<0.001) when dosage reaches 15-20mg/ml.
The strong liver sheet of table 1 is on B16 cell inhibitory effect impact research
Figure BDA00002253892900051
Figure 2012103897467100002DEST_PATH_IMAGE001
Note: with matched group comparison, * P<0.01; * P<0.001
5 experiment conclusion
Strong liver sheet can suppress B16 cell proliferation, reduces the Growth of Cells number of B16 cell, and this effect is dose dependent.

Claims (4)

1. a strong liver sheet suppresses the application in B16 mouse melanoma cell line cell proliferation medicine in preparation, it is characterized in that being good for liver sheet is made as crude drug by Radix Hemerocallis 100g, Radix Isatidis 150g, Herba Artemisiae Scopariae 250g, Radix Salviae Miltiorrhizae 150g, Fructus Jujubae 100g, preparation method is comprised of the following step: get Herba Artemisiae Scopariae, join in CO2 supercritical extraction device, ethanol is as entrainer, and the percent by volume that entrainer accounts for total extractant is 4-6%, extracting pressure 15-30MPa, temperature 30-50 ℃, CO 2flow 1-3m1/g crude drug min, extraction time 150-180min, obtains supercritical extract, standby; Get Radix Hemerocallis, Radix Isatidis, Radix Salviae Miltiorrhizae, Fructus Jujubae, pulverize, add 70% ethanol of 2L, drop in microwave extracting apparatus and carry out microwave extracting, extraction power 400-600W, extracts 2 times, each 4-8 minute, combining extraction liquid, concentrated, be added on polyamide chinlon 66 chromatographic columns, 50% ethanol elution, collects 5 times of amount column volume eluents, decompression recycling ethanol, concentrate and be dried, obtain microwave extraction thing, standby; Above-mentioned supercritical extract and microwave extraction thing are mixed, add starch, 70% ethanol granule processed, dry, tabletting, makes 1000, every heavy 0.5g.
2. a kind of strong liver sheet suppresses the application in B16 mouse melanoma cell line cell proliferation medicine in preparation according to claim 1, it is characterized in that the percent by volume that the supercritical extraction of CO2 described in preparation method entrainer accounts for total extractant is 5%.
3. a kind of strong liver sheet suppresses the application in B16 mouse melanoma cell line cell proliferation medicine in preparation according to claim 1, it is characterized in that the power of microwave extracting described in preparation method 500W, extracts 6 minutes at every turn.
4. a kind of strong liver sheet suppresses the application in B16 mouse melanoma cell line cell proliferation medicine in preparation according to claim 1, it is characterized in that CO described in preparation method 2the extracting pressure 20MPa of supercritical extraction, 40 ℃ of temperature, CO 2flow 2ml/g crude drug min, extraction time 160min.
CN201210389746.7A 2012-10-15 2012-10-15 Preparation method and application of liver-strengthening tablet Active CN102988691B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210389746.7A CN102988691B (en) 2012-10-15 2012-10-15 Preparation method and application of liver-strengthening tablet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210389746.7A CN102988691B (en) 2012-10-15 2012-10-15 Preparation method and application of liver-strengthening tablet

Publications (2)

Publication Number Publication Date
CN102988691A CN102988691A (en) 2013-03-27
CN102988691B true CN102988691B (en) 2014-04-23

Family

ID=47918122

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210389746.7A Active CN102988691B (en) 2012-10-15 2012-10-15 Preparation method and application of liver-strengthening tablet

Country Status (1)

Country Link
CN (1) CN102988691B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104435569A (en) * 2014-11-13 2015-03-25 山东中大药业有限公司 Preparation method of rumex nepalensis and hemerocallis tablet for benefiting liver and application of rumex nepalensis and hemerocallis tablet to preparation of drug for inhibiting proliferation of melanoma cell B16

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1546103A (en) * 2003-12-03 2004-11-17 贵州德祥制药有限责任公司 Liver benefiting Huangxuan Yigan Powder and its preparing process
CN1679898A (en) * 2005-01-13 2005-10-12 刘桂香 Chinese medicine composition for treating hepatitis and cancers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1383880A (en) * 2002-05-20 2002-12-11 张俊峰 Tumor treating pill

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1546103A (en) * 2003-12-03 2004-11-17 贵州德祥制药有限责任公司 Liver benefiting Huangxuan Yigan Powder and its preparing process
CN1679898A (en) * 2005-01-13 2005-10-12 刘桂香 Chinese medicine composition for treating hepatitis and cancers

Also Published As

Publication number Publication date
CN102988691A (en) 2013-03-27

Similar Documents

Publication Publication Date Title
CN102988723B (en) Preparation method and application of traditional Chinese medicine
CN102973667B (en) Preparation method and application of cold-fever tablet
CN102988526B (en) Method for preparing Bailing tablets and application
CN102988667B (en) Preparation method and application of tablet for regulating menstruation and activating blood
CN102988577B (en) Preparation method and application of brain-soothing hypertension pill
CN102988480B (en) Method for preparing bile and patchouli rhinitis tablets and application
CN102988665B (en) Method for preparing gynecological menstruation regulating tablets and application
CN102988612B (en) Preparation method and application of tablet for clearing away heat
CN102988489B (en) Preparation method and application of nose comforting tablet
CN103028005B (en) Preparation method of anti-lumbago tablet and application thereof
CN102988545B (en) Preparation method and application of Yulian tablet
CN102988502B (en) Preparation method and application of Desheng tablet
CN102988479B (en) Preparation method and application of anti-dazzling tablet
CN102988614B (en) Preparation method and application of antiphlogosis tablet
CN102836381B (en) A kind of preparation method of regulating the spleen and stomach sheet and application
CN102988881B (en) Preparation method and application of pulse unblocking tablet
CN102988691B (en) Preparation method and application of liver-strengthening tablet
CN102988611B (en) Preparation method and application of antihypertension tablet
CN103599493A (en) Preparation method and application of liver-restoring tablet
CN102988509B (en) Preparation method and application of bone-knitting tablet
CN102988550A (en) Preparation method and application of qinlian tablet
CN102988501B (en) Preparation method and application of Libiling tablet
CN102988522B (en) Preparation method and application of naodesheng tablets
CN102988749B (en) Preparation method and application of body-building tablet
CN102988748B (en) Preparation method and application of yin tonifying and blood sugar reducing tablet

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: CHONGQING HONOROAD ANIMAL NUTRITION CO., LTD.

Free format text: FORMER OWNER: LI ZHENGMEI

Effective date: 20140325

C41 Transfer of patent application or patent right or utility model
C53 Correction of patent for invention or patent application
CB03 Change of inventor or designer information

Inventor after: Li Biying

Inventor before: The inventor has waived the right to be mentioned

COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 211200 NANJING, JIANGSU PROVINCE TO: 401122 YUBEI, CHONGQING

Free format text: CORRECT: INVENTOR; FROM: REQUEST NOT TO RELEASE THE NAME TO: LI BIYING

TA01 Transfer of patent application right

Effective date of registration: 20140325

Address after: 401122 Chongqing City, Yubei District economic and Technological Development Zone by opening C40-C4

Applicant after: CHONGQING HONOROAD ANIMAL HEALTH CO., LTD.

Address before: 211200, No. 1, Shandong Road, Lishui Economic Development Zone, Nanjing, Jiangsu

Applicant before: Li Zhengmei

C14 Grant of patent or utility model
GR01 Patent grant